Platelets Activation in Brain Neoplasms

Platelets are primarily known for their central role in primary hemostasis. However, they are increasingly recognized for their participation in various non-hemostatic processes, such as cancer progression and clinical expression. Experimental and clinical data indicate that the involvement of platelets in the pathophysiology of cancer goes far beyond the realm of cancer-associated thrombosis. Several experimental studies have shown that platelets can promote the metastatic process by various mechanisms. However, while it has been shown in vitro that direct contact with platelets initiates tu

Trial Details

NCT ID
NCT05049148
Phase
NA
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Status
RECRUITING
Cancer Type
Brain Cancer
Interventions
  • Platelet count in excised tumors
Locations (sample)
  • Paris, France|48.85341,2.3488

Key Eligibility Criteria

  • Patient to undergo excision or biopsy of a brain or medullary tumor
  • Patient over 18 years old
  • Express consent to participate in the study
  • Affiliate member of the Social Security system

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →